Home Analyst Ratings Goldman Sachs maintains Cree Inc. ’s rating to Neutral and price target...

Goldman Sachs maintains Cree Inc. [CREE]’s rating to Neutral and price target at $77

Goldman Sachs maintained its Cree Inc. [NASDAQ:CREE] ‎rating to the equivalent of Neutral but ‎changed the price target ‎to $77 ‎from $67, in a research note dated December 29, 2020. Other analysts ‎also revised their coverage, with Morgan Stanley’s analysts downgrading the shares ‎from “an ‎Overweight” rating to “an Equal-weight” rating in a research note to investors issued in ‎early ‎December. Meanwhile, JP Morgan had raised its rating on CREE to “an Overweight” from the ‎earlier ‎‎”Neutral”, in a research note produced for clients November 20, 2020. In addition, there was ‎an ‎upgrade from JP Morgan on November 19, 2020. The rater changed CREE from “a Neutral” to ‎‎”an ‎Overweight”.

Get the hottest stocks to trade every day before the ‎market ‎opens 100% free. Click here now. 

Is Cree Inc. [NASDAQ:CREE] a Good Buy Right Now?

It should be noted that CREE ‎technical ‎indicators for short, intermediate as well as long term progress have placed an overall ‎average of 100% ‎as Buy. The average signal changed from 100% Buy in the last week and compares ‎with 100% Buy in the ‎past month. Data from Cree Inc.’s Trend Spotter indicated that the signals were ‎Weakest. The stock ‎current average is 1.79 million shares in the past 20 days and the short term ‎average signal indicates a ‎‎100% Buy. In the last 50 days, the average trading volume was 1.55 million ‎shares while the medium ‎term average advocated for 100% Buy. The average long-term signal stands ‎at 100% Buy and the 100-‎day average volume stands at 1.34 million shares.‎‎


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


CREE Price Performance

On Wall Street, Cree Inc. [NASDAQ:CREE] finished ‎Monday’s ‎session down -2.02% at $101.02. The stock went up to $105.93 at the same session while its ‎lowest ‎single day price was $100.5012. In the last five days, it saw a rise of about 3.38%, Cree Inc. ‎shares ‎gained by almost 118.89% since the beginning of the year. However, the share price has ‎dropped to as ‎low as -4.67% below its one year high. On 12/23/20, the company shares recorded ‎‎$105.97, the highest ‎single-day price it has got to in the last 52-weeks and a 52-week low was seen on ‎‎03/17/20, the same ‎year at $27.77. The company’s shares have inclined by 115.35% in the past year. ‎The 50-day SMA ‎achieved is $81.60 while the 200-day SMA is $62.21. Volume gained to 1.29 million ‎from 1.19 million in ‎the previous session.‎‎

CREE Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing ‎is ‎perceived around 99.04 level, and in case of violation of this particular level, it will cause more drop ‎to ‎‎97.05 level. On the upper level, 107.91 is still the key resistance. The stock may increase to ‎the ‎subsequent resistance at 104.47. The Relative Strength Index (RSI) pinned on the 14-day chart is ‎‎65.24, ‎implying a neutral technical stance while the MACD stands at 5.77, meaning price will increase in ‎the ‎next trading period. Percent R indicator moved to 31.46%, implying low price movement. ‎Stochastic %K ‎at 77.35% suggest selling the stock.‎‎

What is the short interest in Cree Inc.?

Short interest in the Cree Inc. stock has ‎plunged, ‎decreasing by -1.03 million shares to total 13.5 million shares on Dec 14, 2020. The interest ‎had seen ‎shares on Nov 12, 2020 stand at 12.47 million, data from Yahoo Finance shows. The increase ‎of 7.63% ‎suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ‎ratio) ‎moved to while the shorted shares account for just 13.86% of the overall float for the stock.‎‎

Cree Inc.’s Biggest Shareholders: Who Owns Cree Inc. [CREE]?

Filings by Capital Research ‎& ‎Management Co showed that the firm now holds a total of 13,435,964 shares or roughly 12.18% of ‎the ‎outstanding CREE shares. This means their shares have increased by 330,746 from the 13,435,964 ‎the ‎investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, The ‎Vanguard ‎Group, Inc. updated stake is worth $881,698,047. Details in the latest 13F filings reveal that ‎BlackRock ‎Fund Advisors disposed off their -2.23% stake valued at $786,420,027 while ClearBridge ‎Investments ‎LLC cut theirs at $756,510,247. During the last quarter, BlackRock Fund Advisors liquidated ‎‎-198,221 of ‎its shares in Cree Inc. while ClearBridge Investments LLC sold -340,721 shares. The ‎PRIMECAP ‎Management Co.’s holdings currently number 6,047,489 shares at $610917338.78. According ‎to the ‎firm’s last 13F report, Capital Research & Management Co shares in the company at filing stood ‎at ‎‎5,646,653 shares, roughly $510,400,965.‎‎

CREE Earnings Forecast For The Current Quarter

Cree Inc. [CREE] is expected to report ‎weak ‎earnings results for the quarter ending on Dec 2020. Consensus estimates give the company ‎expected ‎revenues of $121.6M and an earnings per share of -$0.25 for Dec 2020. Looking further ‎ahead, the ‎company is expected to report revenue of $128.54M at an EPS of -$0.2 for Mar 2021. The ‎estimates ‎represent downside of 10.30% and 61.50% in the company’s revenue and earnings per ‎share, ‎respectively, on a year-on-year basis.‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

CREE Earnings Estimates For The ‎Current ‎Year

For the financial year, Cree Inc. [NASDAQ:CREE] is expected to bring in revenue ‎of ‎‎$633.92M. The returns are nearly $-269.98 million lower than the company’s actual revenue ‎recorded ‎in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at -0.78, lower than that of ‎FY20 by -‎‎$0.33. Estimates put this year’s earnings growth at -73.30%, 61.50% for the next, and at an ‎annual -‎‎20.64% over the next 5-year period. As for sales, forecasts are for a decrease of -29.90% in the ‎current ‎fiscal year and a further 10.30% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

Acorda Therapeutics Inc. (ACOR) stock plunged during pre-market. Here’s what you should know.

Acorda Therapeutics Inc. (ACOR) stock rose by 24.15% at the last close whereas the ACOR stock price fell by 9.30% in the pre-market trading...

Why Socket Mobile Inc. (SCKT) stock price faced negativity in the pre-market?

Socket Mobile Inc. (SCKT) shares declined 10.18% in pre-hours to $7.50 per share. On Friday, SCKT's stock gained 43.97% to close Friday's morning session...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam